The NCI Sarcoma Steering Committee (Sarcoma SC) was established in 2025. At quarterly meetings, it addresses the design, prioritization, and evaluation of concepts for phase 2 and phase 3 treatment trials in adult sarcomas. View the Sarcoma SC member roster. The committee may periodically hold clinical trials planning meetings (CTPMs) to focus on specific clinical trial related topics.
Contact
For more information, contact NCI CCCT Program Director, Ramy Serour, M.S., at ramy.serour@nih.gov.